BASILE, DEBORA
 Distribuzione geografica
Continente #
NA - Nord America 1.080
EU - Europa 151
AS - Asia 83
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.318
Nazione #
US - Stati Uniti d'America 1.077
IT - Italia 60
CN - Cina 44
UA - Ucraina 23
IE - Irlanda 22
VN - Vietnam 22
DE - Germania 15
BE - Belgio 8
IN - India 8
SE - Svezia 7
GB - Regno Unito 6
IR - Iran 6
FR - Francia 4
RU - Federazione Russa 4
CA - Canada 3
HK - Hong Kong 2
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
RO - Romania 1
TG - Togo 1
TR - Turchia 1
Totale 1.318
Città #
Fairfield 156
Chandler 147
Ashburn 116
Woodbridge 63
Ann Arbor 57
Seattle 57
Houston 52
Wilmington 47
Cambridge 40
Beijing 28
New York 25
Princeton 24
Dong Ket 22
Dublin 22
Martignacco 20
Dearborn 17
San Diego 11
Washington 11
Jacksonville 10
Brussels 8
Ogden 8
Udine 7
Ardabil 5
Bologna 5
Leawood 5
Los Angeles 5
Norwalk 5
Redmond 4
Caserta 3
Des Moines 3
Jinan 3
Milan 3
Nanjing 3
Toronto 3
Augusta 2
Edinburgh 2
Hong Kong 2
Phoenix 2
San Mateo 2
Wenzhou 2
Asti 1
Bangalore 1
Boardman 1
Boston 1
Cairo 1
Catania 1
Chengdu 1
Duncan 1
Florence 1
Fuzhou 1
Grafing 1
Hefei 1
Izmir 1
Kunming 1
Langfang 1
Lomé 1
Lviv 1
Mortegliano 1
Moscow 1
Nanchang 1
Naples 1
Paris 1
Partanna 1
Prague 1
Redwood City 1
Romans 1
Rutigliano 1
Shenzhen 1
Trento 1
Trieste 1
Tuenno 1
Wuhan 1
Totale 1.039
Nome #
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 139
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 101
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 95
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 88
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 82
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients 61
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 60
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 55
Time to surgery after neoadjuvant chemotherapy for early breast cancer 51
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 40
Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients 38
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 38
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 37
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 33
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 31
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 30
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 28
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study 23
How I treat stage II colon cancer patients 21
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 20
State-of-the-art of monoclonal antibodies for the treatment of gastric cancer 11
Totale 1.395
Categoria #
all - tutte 5.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 6 5
2019/2020345 4 16 13 32 28 40 32 48 60 29 32 11
2020/2021334 18 9 24 51 32 20 12 44 8 27 38 51
2021/2022230 26 24 3 7 10 3 16 8 1 25 82 25
2022/2023298 25 39 8 28 35 58 1 28 50 4 12 10
2023/2024165 20 5 12 11 22 67 0 7 15 6 0 0
Totale 1.395